Skip to main content

Table 2 Relationship between ZNF703 expression and clinicopathological parameters of ovarian epithelial malignant tumors

From: ZNF703 promotes tumor progression in ovarian cancer by interacting with HE4 and epigenetically regulating PEA15

Groups

Cases

Low

High

Positive rate (%)

P-value

High expression rate (%)

P-value

(−)

(+)

(++)

(+++)

FIGO stage

 I-II

38

8

11

12

7

78.9%

P = 0.209

50.0%

P = 0.101

 III-IV

60

7

13

16

24

85.5%

66.7%

Differentiation

 Well- Moderate

49

9

14

14

12

81.6%

P = 0.4

53.1%

P = 0.149

 Poor

49

6

10

14

19

87.8%

67.3%

Lymphatic metastasis

 No

62

8

16

22

16

87.1%

P = 0.582

61.3%

P = 0.808

 Yes

29

5

7

5

12

82.8%

58.6%

 Unknowna

7

2

1

1

3

71.4%

57.1%

Pathological type

 Serous

45

6

11

13

15

86.7%

P = 0.158

62.2%

P = 0.440

 Mucinous

9

3

1

2

3

66.7%

55.6%

 Endometrioid

15

3

4

4

4

80%

53.3%

 Clear cell carcinoma

7

2

3

1

1

71.4%

28.6%

 Poorly differentiated adenocarcinoma

22

1

6

5

10

95.5%

68.2%

  1. Note: a 7 patients without lymphadenectomy